Similar Search Results

The pharmaceutical market in the people's Republic of China in transition : current situation and development trends

Chou, Yu-Wen - 2008

Persistent link: https://www.econbiz.de/10003756813

Effects of pharmaceutical price regulation : China's evidence between 1997 and 2008

Wu, Binzhen; Zhang, Qiong; Qiao, Xue - In: Journal of the Asia Pacific economy 20 (2015) 2, pp. 290-329

Persistent link: https://www.econbiz.de/10011378658

Effects of China's Pharmaceutical Price Regulation between 1997 and 2008

Wu, Binzhen - 2014

This paper uses macro-level data between 1997 and 2008 to evaluate the effects of China's pharmaceutical price regulations. We find that these regulations had short-run effects on medicine price indices, reducing them by less than 0.5 percentage points. The effects could have been slightly...

Persistent link: https://www.econbiz.de/10013066440

The Globalization of Innovation : Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market

Wadhwa, Vivek; Rissing, Ben A.; Gereffi, G.; Trumpbour, John - 2014

Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These...

Persistent link: https://www.econbiz.de/10014047447

Public health insurance and pharmaceutical innovation : evidence from China

Zhang, Xuan; Nie, Huihua - In: Journal of development economics 148 (2021), pp. 1-27

Persistent link: https://www.econbiz.de/10012658986

Health policy, price regulation, and innovation : evidence from China's vaccine industry

Geng, Hao; Shi, Ce Matthew - In: Journal of development economics 167 (2024), pp. 1-22

Persistent link: https://www.econbiz.de/10014454554

Improving Regulation for Innovation : Evidence from China's Pharmaceutical Industry

Jia, Ruixue; Ma, Xiao; Yang, Jianan; Zhang, Yiran - National Bureau of Economic Research - 2023

This study investigates how enhanced regulation can promote innovation, focusing on the impacts of a significant … recognized the improvement in drug innovation, as reflected in stock price adjustments post new drug registrations after the … latecomers could boost their innovation potential by adopting specific, effective regulatory practices from frontier countries …

Persistent link: https://www.econbiz.de/10014447297

Improving regulation for innovation : evidence from China's pharmaceutical industry

Jia, Ruixue; Ma, Xiao; Yang, Jianan; Zhang, Yiran - 2023

Persistent link: https://www.econbiz.de/10014443086

China's pharmaceutical market: business environment and market dynamics

Brueckner, Michael; Philipp, Marc P.; Luithle, Joachim E. A. - In: The chemical and pharmaceutical industry in China : …, (pp. 91-107). 2005

Persistent link: https://www.econbiz.de/10002960708

A Generic Drug Policy as Cornerstone to Essential Medicines in China

World Bank - 2010

Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative perspective is not particularly high on a per capita basis or as a percentage of GDP....

Persistent link: https://www.econbiz.de/10012247334

1
2
3
4
5
6
7
8
9
10
Next
Last